Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis

Area of Science:

• Neuroscience
• Infectious Diseases
• Neurosurgery

Background:

• Cryptococcal meningitis (CM) presents challenges with persistent intracranial hypertension (ICH) and high Cryptococcus counts.
• The efficacy of ventriculoperitoneal shunts (VPS) in non-HIV CM patients remains under-investigated.
• This study reviews the role of VPS in managing non-HIV CM.

Purpose of the Study:

• To investigate the therapeutic role and outcomes of ventriculoperitoneal shunts (VPS) in non-HIV cryptococcal meningitis (CM) patients.
• To assess the impact of VPS on intracranial hypertension and fungal burden.
• To determine optimal timing for VPS intervention in non-HIV CM.

Main Methods:

• Retrospective analysis of 23 non-HIV CM patients (2010-2016).
• Inclusion of patients with and without ventriculomegaly.
• Analysis of demographic data, clinical features, CSF analysis, and patient outcomes.

Main Results:

• Patients without ventriculomegaly were older with shorter symptom duration and earlier treatment.
• Headache, vomiting, fever, and vision loss were common symptoms in both groups.
• VPS significantly reduced CSF pressure and Cryptococcus counts, providing sustained ICH symptom relief.
• 87% of patients achieved good outcomes, while 13% had poor outcomes due to comorbidities.

Conclusions:

• Ventriculoperitoneal shunts (VPS) are effective in managing intracranial hypertension and reducing fungal load in non-HIV CM.
• VPS placement is recommended prior to the onset of severe neurological deficits in non-HIV CM patients.
• Early intervention with VPS can lead to favorable patient outcomes.